Ohmeda's medical equipment service policy targeted in Nov. 1 suit by independent servicers.
This article was originally published in The Gray Sheet
Executive Summary
OHMEDA'S MEDICAL EQUIPMENT SERVICE POLICY TARGETED IN LAWSUIT filed by 13 independent medical equipment service providers on Nov. 1. The suit, filed in the U.S. District Court in Sacramento, California, accuses Ohmeda of antitrust violations stemming from its alleged refusal to make spare parts, equipment repair training, and component repair services available to independent service organizations (ISOs) which compete with Ohmeda to provide maintenance of Ohmeda medical equipment. The plaintiffs are seeking injunctive relief, treble damages, costs and attorney's fees.
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.